PARP1 and cancer: PARP1 is overexpressed in multiple cancer types including breast cancer [106,107,108,109], small cell lung cancer [110], nasopharyngeal carcinoma [111], acute myeloid leukemia [112], high-grade epithelial ovarian cancer [113], and colorectal carcinoma [114], often with poor outcomes.